Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.900 | strong | 0.954 | 1 | 0 | 1995 | 2019 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
disease | 0.600 | None | 0.952 | 3 | 0 | 1996 | 2020 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
disease | 0.300 | None | 0.800 | 2 | 0 | 1996 | 2019 | ||||||||
|
NADH dehydrogenase, subunit 1 (complex I) | 0.522 | 0.769 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1996 | 2008 | |||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.900 | strong | 0.943 | 1 | 0 | 1996 | 2019 | ||||||||
|
insulin receptor substrate 2 | 0.535 | 0.654 | 0.99 |
|
disease | 0.700 | None | 0.975 | 9 | 0 | 1997 | 2017 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1997 | 2006 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 1998 | 2012 | ||||||||
|
uncoupling protein 2 | 0.493 | 0.808 | 1.5E-10 |
|
disease | 0.600 | None | 0.857 | 2 | 0 | 1998 | 2019 | ||||||||
|
glucose-6-phosphatase catalytic subunit | 0.560 | 0.692 | 1.8E-05 |
|
disease | 0.280 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
uncoupling protein 3 | 0.619 | 0.577 | 9.6E-10 |
|
disease | 0.300 | None | 0.931 | 1 | 0 | 1998 | 2020 | ||||||||
|
pancreatic and duodenal homeobox 1 | 0.530 | 0.654 | 1.8E-02 |
|
disease | 0.700 | None | 0.956 | 1 | 0 | 1998 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.600 | None | 0.950 | 1 | 0 | 1999 | 2020 | ||||||||
|
paired box 4 | 0.644 | 0.423 | 4.2E-04 |
|
disease | 1.000 | limited | 0.857 | 1 | 0 | 1999 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.600 | None | 0.900 | 1 | 0 | 1999 | 2019 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.270 | None | 0.875 | 2 | 0 | 2000 | 2018 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
calpain 10 | 0.621 | 0.577 | 6.9E-13 |
|
disease | 0.700 | None | 0.926 | 2 | 0 | 2000 | 2019 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
insulin degrading enzyme | 0.604 | 0.577 | 6.6E-03 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.210 | None | 1.000 | 0 | 0 | 2000 | 2000 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.944 | 2 | 0 | 2001 | 2019 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.925 | 2 | 0 | 2001 | 2020 |